A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers

Overview of attention for article published in EJNMMI Research, February 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 6 publications that cite this research output.

6

The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.

Neoadjuvant chemotherapy for high-grade serous ovarian cancer: radiologic–pathologic correlation of response assessment and predictors of progression

Article in Abdominal Radiology (March 2024)

68Ga–Prostate-Specific Membrane Antigen PET/CT in Ovarian Tumors

Article in Clinical Nuclear Medicine (November 2022)

PSMA Expression in Solid Tumors beyond the Prostate Gland: Ready for Theranostic Applications?

Article in Journal of Clinical Medicine (November 2022)